home / stock / gwph / gwph news


GWPH News and Press, GW Pharmaceuticals Plc From 04/09/20

Stock Information

Company Name: GW Pharmaceuticals Plc
Stock Symbol: GWPH
Market: NASDAQ
Website: gwpharm.com

Menu

GWPH GWPH Quote GWPH Short GWPH News GWPH Articles GWPH Message Board
Get GWPH Alerts

News, Short Squeeze, Breakout and More Instantly...

GWPH - CBD International Sales Opportunity Will Attract Industry Again After Coronavirus Pandemic Eases

International sales attracted CBD companies until the coronavirus pandemic created lockdowns of countries and shut economies. Now, as the second half re-opening of countries is anticipated, CBD companies may look beyond domestic markets and, once again, see the opportunities in other countries. ...

GWPH - Todd Davis, CEO of CBD Unlimited, Inc., In Breakthrough, Enables Customers To Manage Own E-Commerce Subscription Accounts

Todd Davis, CEO of CBD Unlimited, Inc., has performed an important industry breakthrough service by revamping the company’s e-commerce website platform by enabling customers to manage their own subscription accounts, giving them more confidence in buying CBD online. Not only does the re...

GWPH - CBD Sales Projection Of $2.1 Billion In 2020 Must Be Re-Thought After Coronavirus Pandemic

Prior to the coronavirus pandemic, Forbes had quoted a projection of $2.1 billion for CBD consumer retail sales in 2020 from Hemp Business Journal . It also said that $450 million of those sales would come from hemp-based sources. But the coronavirus pandemic has thrown all retail sales his...

GWPH - The DEA Has Descheduled Prescription CBD for Severe Epilepsy

Parents of children with early-onset epilepsy and their physicians will find it easier to fill their next Epidiolex prescriptions. That's because the CBD tincture from GW Pharmaceuticals (NASDAQ: GWPH) is no longer under the thumb of the Drug Enforcement Agency (DEA).  Epidiolex launch...

GWPH - GW Pharma's Epidiolex descheduled by DEA

The U.S. Drug Enforcement Agency (DEA) has notified GW Pharmaceuticals (NASDAQ: GWPH ) that it no longer considers Epidiolex (cannabidiol) a controlled substance. The change is effective immediately. More news on: GW Pharmaceuticals plc, Healthcare stocks news, Stocks on the move, ...

GWPH - GW Pharmaceuticals plc and Its U.S. Subsidiary Greenwich Biosciences, Inc. Announce That EPIDIOLEX® (cannabidiol) Oral Solution Has Been Descheduled And Is No Longer A Controlled Substance

- Descheduling will enable prescribing free of the previous Schedule V requirements - CARLSBAD, Calif., April 06, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focus...

GWPH - 2 Marijuana Stocks To Watch In April

Risk is something that is quite common in the cannabis industry . Whether investing in the short or the long term, cannabis stock investors usually encounter risk on a daily basis. Because of this, it can be a great tool to develop a strategy to stick with no matter what happens in the industry...

GWPH - CBD Unlimited, Inc. Debuts Revamped E-Commerce Sales Platform, Plans To Intro-duce Rebrand Of Topical Line

In a NASDAQ MarketSite interview with reporter Jane King, CBD Unlimited, Inc.’s ( OTC PINK: EDXC ) Todd Davis, CEO, today (April 6, 2020) announced that the company has developed a revamped e-commerce platform enabling customers, new and existing, to establish and manage their online ...

GWPH - CBD Unlimited, Inc. Reports $1+ Million Record Volume In Q2, Generates Accelerated Growth Curve Year-Over-Year

CBD Unlimited, Inc. ( OTC PINK: EDXC ) today (April 6, 2020) reports $1+ Million record volume for its second quarter ended March 31, reflecting an accelerated growth curve year-over-year. It recorded an order of $1 million and recognized it in this quarter. In an updated interview with NASD...

GWPH - Innovation In Pharmaceutical And CBD Sales During Coronavirus Shut Down Is Effective Strat-egy

Virtual meetings and digital presentations are one way for pharmaceutical companies to continue to sell retailers during the coronavirus shelter-at-home edicts. This is the strategy for Bayer (NYSE: BAYRY) , Pfizer (NYSE: PFE) , Merck (NYSE: MRK ), GlaxoSmithKline (NYSE: GSK ) and ...

Previous 10 Next 10